JCRB1351 Int-3LL
Cell information
Important Notice(s)Lewis lung carcinoma (3LL): Culture medium
Cell type：general cells (View Pricing Information)
| JCRB No. | JCRB1351 | Cell Name | Int-3LL |
|---|---|---|---|
| Profile | Variant cell line possessing enhanced intravasating ability derived from Lewis lung cancer (3LL). | Other Name | |
| Animal | mouse | Strain | |
| Genus | Mus | Species | musculus |
| Sex | Age | ||
| Identity | not done | Tissue for Primary Cancer | lung |
| Case history | Metastasis | Yes | |
| Tissue Metastasized | Genetics | ||
| Life Span | infinite | Crisis PDL | |
| Morphology | fibroblast-like | Character | Lewis lung carcinoma derived cell line enhanced intravasating ability. |
| Classify | tumor | Established by | Ota, T |
| Registered by | Ota, T | Regulation for Distribution | |
| Comment | Year | 2008 | |
| Medium | Hams F10:L15=3:7 medium with 10% heat-inactivated fetal bovine serum. (Current medium for propagation: RPMI-1640 medium with 10% FBS) | Methods for Passages | Cells were harvested with pipetting. |
| Cell Number on Passage | -- | Race | |
| CO2 Conc. | 5% | Tissue Sampling | |
| Tissue Type |
| Detection of virus genome fragment by Real-time PCR | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Detected DNA Virus | not tested | Detected RNA Virus | not tested | ||||||
| Reference | |
|---|---|
| Pubmed id:11299736 | Functional suppression of integrin beta 4-mediated adhesion caused by in vivo sequential selection for cancer cell intravasation. Ota T,Maeda M,Tanino M,Tatsuka M Anticancer Res. 2001 Jan-Feb;21(1A):205-11 |
| Pubmed id:10408901 | Decrease of metastatic ability after selection for intravasating ability in Lewis lung carcinoma (3LL) cell line. Ota T,Maeda M,Tatsuka M,Matsui T,Tanino M,Tanaka T Cancer Lett. 1999 May 3;139(1):105-8 |
| Images |
|---|
      |
LOT Information
Viability/Growth rate/Cell number are represented as actual values measured at lot presentation in JCRB, but are not guaranteed values. Additionally, the doubling time is a rough value measured during passages.| Cell No. | JCRB1351 | Cell Name | Int-3LL |
|---|---|---|---|
| LOT No. | 11162009 | Lot Specification | distribution |
| Medium | RPMI1640 medium(GIBCO) with 10% heat inactivated fetal bovine serum(SIGMA027K03911) | Temperature | 37 C |
| Cell Density at Seeding | 1.1-4.3x10^4 cells/ml | Methods for Passages | Cells were harvested with pipetting. |
| Doubling Time | NT | Cell Number in Vial (cells/1ml) | 5.5x10^6 |
| Viability at cell freezing (%) | 96.2 | Antibiotics Used | free |
| Passage Number | p4* | PDL | NT |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | NT |
| Chromosome Mode | NT | Chromosome Information | NT |
| Surface Antigen | NT | DNA Profile (STR) | |
| Adhesion | No | Exoteric Gene | NT |
| Medium for Freezing | Cell Banker BLC-1(Nihon Zenyaku Industries) | CO2 Conc. | 5 % |
| Viability immediately after thawing (%) | Additional information |
| Images |
|---|
|
|
| Cell No. | JCRB1351 | Cell Name | Int-3LL |
|---|---|---|---|
| LOT No. | 02142017 | Lot Specification | distribution |
| Medium | RPMI-1640 medium with 10% heat-inactivated fetal bovine serum (FBS; Sigma Cat. # 172012). | Temperature | 37 C |
| Cell Density at Seeding | 1.6 - 2.2 x 10^5 cells/mL | Methods for Passages | Cells were harvested by pipetting. |
| Doubling Time | approx. 43 hrs. | Cell Number in Vial (cells/1ml) | 3.4 x 10^6 |
| Viability at cell freezing (%) | 76.7 | Antibiotics Used | free |
| Passage Number | Unknown (6 at bank) | PDL | |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | |
| Chromosome Mode | Chromosome Information | ||
| Surface Antigen | DNA Profile (STR) | ||
| Adhesion | Yes | Exoteric Gene | |
| Medium for Freezing | 10% DMSO, 20% FBS - RPMI1640 | CO2 Conc. | 5% |
| Viability immediately after thawing (%) | 76.7 | Additional information |